References
- Schick B, Urbschat S. New aspects of pathogenesis of juvenile angiofibroma. Hosp Med 2004;65:269–73.
- Beham A, Beham-Schmid C, Regauer S, Auböck L, Stammberger H. Nasopharyngeal Angiofibroma. True neoplasm or vascular malformation? Adv Anat Pathol 2000;7:36–46.
- Starlinger V, Wendler O, Gramann M, Schick B. Laminin expression in juvenile angiofibroma indicate vessel`s early developmental stage. Acta Otolarnygol 2007;127:1310–15.
- Gramann M, Wendler O, Haeberle L, Schick B. Expression of collagen types I, II and III in juvenile angiofibromas. Cells Tissues Organs 2009;189:403–9.
- Schick B, Wemmert S, Willnecker V, Dlugaiczyk J, Nicolai P, Siwiec H, et al. Genome-wide copy number profiling using a 100K SNP array reveals novel disease-related genes BORIS and TSHZ1 in juvenile angiofibroma. Int J Oncol 2011;39:1143–51.
- Gurzu S, Ciortea D, Munteanu T, Kezdi-Zaharia I, Jung I. Mesenchymal-to-endothelial transition in Kaposi sarcoma: a histogenetic hypothesis based on a case series and literature review. PLoS One 2013;8:1–7.
- Brieger J, Wierzbicka M, Sokolov M, Roth Y, Szyfter W, Mann WJ. Vessel density, proliferation and immunolocalization of vascular endothelial growth factor in juvenile nasopharyngeal angiofibromas. Arch Otolaryngol Head Neck Surg 2004;130:727–31.
- Liu Z, Wang J, Wang H, Wang D, Hu L, Liu Q, et al. Hormonal receptors and vascular endothelial growth factor in juvenile nasopharyngeal angiofibroma: immunohistochemical and tissue microarray analysis. Acta Otolaryngol 2015;135:51–7.
- Schiff M, Gonzalez AM, Ong M, Baird A. Juvenile nasopharyngeal angiofibroma contain an angiogenic growth factor: basic FGF. Laryngoscope 1992;102:940–5.
- Léaute-Labreze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taieb A. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008;358:2649–51.
- Lamy S, Lachambre MP, Lord-Dufour S, Béliveau R. Propranolol suppresses angiogenesis in vitro: inhibition of proliferation, migration, and differentiation of endothelial cells. Vascul Pharmacol 2010;53:200–8.
- Hajighasemi F, Mirshafiey A. Propranolol effect on proliferation and vascular endothelial growth factor secretion in human immunocompetent cells. J Clinl Immunol Immunopathol Res 2010;2:22–7.
- Zwergel T, Kakirman H, Schorr H, Wullich B, Unteregger G. A new serial transfer explant cell culture system for human prostatic cancer tissues preventing selection toward diploid cells. Cancer Genet Cytogenet 1998;101:16–23.
- Wendler O, Schäfer R, Schick B. Mast cells and T-lymphocytes in juvenile angiofibromas. Eur Arch Otorhinolaryngol 2007;264:769–75.
- Schick B, Dlugaiczyk J, Wendler O. Expression of sex hormone receptors in juvenile angiofibromas and anti-proliferative effects of receptor modulators. Head Neck 2014;36:1596–603.
- Nicosia RF, Ottinetti A. Growth of microvessels in serum-free matrix culture of rat aorta. A quantitative assay of angiogenesis in vitro. Lab Invest 1990;63:115–12.
- Glad H, Vainer B, Buchwald C, Petersen BL, Theilgaard SA, Bonvin P, et al. Juvenile nasopharyngeal angiofibromas in Denmark 1981-2003: diagnosis, incidence, and treatment. Acta Otolaryngol 2007;127:292–9.
- Renkonen S, Häyry V, Heikkilä P, Leivo I, Haglund C, Mälitie AA, et al. Stem cell-related proteins C-KIT, C-MYC and BMI-1 in juvenile nasopharyngeal angiofibroma – do they have a role? Virch Arch 2011;458:189–95.
- Schick B, Wemmert S, Jung V, Steudel WI, Montenarh M, Urbschat S. Genetic heterogeneity of the myc oncogene in advanced juvenile angiofibromas. Cancer Genet Cytogenet 2006;164:25–31.
- Shikani AH, Richtsmeier WJ. Juvenile nasopharyngeal angiofibroma tumor models. Failure of androgens to stimulate growth in nude mice and in vitro. Arch Otolaryngol Head Neck Surg 1992;118:256–9.